Main description:

Chronic Kidney Disease (CKD) is a recognized risk factor for cardiovascular events and death. The coexistence of CKD and heart failure is increasing in prevalence worldwide and requires a unique and subtle approach to patient management.

The Kidney in Heart Failure focuses on the changes that occur in kidney physiology as a function of a failing heart. This comprehensive resource covers epidemiology, pathophysiology, management of kidney disorders and advances in nephropathy management. In addition, the latest therapies, common heart failure dilemmas and kidney disease markers are included. Each chapter is co-authored by a Nephrologist and Cardiologist, offering a unified perspective to these chronic conditions.

This indispensible volume provides the reader with the depth-of-knowledge needed for assessing and treating the cardio renal patient.

Contents:

Foreword Peter A. McCulloughPrefacePart One EpidemiologyChapter 1 Epidemiology of Chronic Kidney Disease in Heart Failure

Ruth C. Campbell and Ali Ahmed

Chapter 2 Anemia and Cardiovascular Risk in the Kidney Disease Patients:

What is the best way to achieve and what is the desired hemoglobin?

Tejas V. Patel and Ajay K. Singh

Part Two PathophysiologyChapter 3 Renal Hemodynamic Changes in Heart Failure Ivana Lazich and George L. Bakris

Chapter 4 Changes in Kidney Function Following Heart Failure Treatment: Focus on RAS Blockade Mohammed Shakaib and George L. Bakris

Chapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient

Biff F. Palmer

Chapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications

Ivan D. Hanson and Peter A. McCullough

Part Three Management of Kidney Associated Clinical ProblemsChapter 7 Hyperkalemia Risk and Treatment of Heart Failure

Julian Segura and Luis M. Ruilope

Chapter 8 Management of Heart Failure with Renal Artery Ischaemia

Andrew K. Roy and Patrick Murray

Chapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure

Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir

Chapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment Options Domenic A. Sica

Chapter 11 Ultrafiltration and Heart Failure

Paul Chacko, Donald Kikta Jr., William T. Abraham

Part Four Advances in Nephropathy Management: Influences on CVD RiskChapter 12 Combination Therapy in Hypertension Treatment

Raymond V. Oliva and George L. Bakris

Chapter 13 Medication Adherence in Heart Failure

Daniel E. Hilleman and Jennifer A. Campbell

Chapter 14 New Markers of Vascular Risk

David Davidson and Michael H. Davidson

Chapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD

Raghu V. Durvasula and Katherine R. Tuttle

PrefacePart One EpidemiologyChapter 1 Epidemiology of Chronic Kidney Disease in Heart Failure

Ruth C. Campbell and Ali Ahmed

Chapter 2 Anemia and Cardiovascular Risk in the Kidney Disease Patients:

What is the best way to achieve and what is the desired hemoglobin?

Tejas V. Patel and Ajay K. Singh

Part Two PathophysiologyChapter 3 Renal Hemodynamic Changes in Heart Failure Ivana Lazich and George L. Bakris

Chapter 4 Changes in Kidney Function Following Heart Failure Treatment: Focus on RAS Blockade Mohammed Shakaib and George L. Bakris

Chapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient

Biff F. Palmer

Chapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications

Ivan D. Hanson and Peter A. McCullough

Part Three Management of Kidney Associated Clinical ProblemsChapter 7 Hyperkalemia Risk and Treatment of Heart Failure

Julian Segura and Luis M. Ruilope

Chapter 8 Management of Heart Failure with Renal Artery Ischaemia

Andrew K. Roy and Patrick Murray

Chapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure

Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir

Chapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment Options Domenic A. Sica

Chapter 11 Ultrafiltration and Heart Failure

Paul Chacko, Donald Kikta Jr., William T. Abraham

Part Four Advances in Nephropathy Management: Influences on CVD RiskChapter 12 Combination Therapy in Hypertension Treatment

Raymond V. Oliva and George L. Bakris

Chapter 13 Medication Adherence in Heart Failure

Daniel E. Hilleman and Jennifer A. Campbell

Chapter 14 New Markers of Vascular Risk

David Davidson and Michael H. Davidson

Chapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD

Raghu V. Durvasula and Katherine R. Tuttle

Ivana Lazich and George L. Bakris

Chapter 4 Changes in Kidney Function Following Heart Failure Treatment: Focus on RAS Blockade Mohammed Shakaib and George L. Bakris

Chapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient

Biff F. Palmer

Chapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications

Ivan D. Hanson and Peter A. McCullough

Part Three Management of Kidney Associated Clinical ProblemsChapter 7 Hyperkalemia Risk and Treatment of Heart Failure

Julian Segura and Luis M. Ruilope

Chapter 8 Management of Heart Failure with Renal Artery Ischaemia

Andrew K. Roy and Patrick Murray

Chapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure

Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir

Chapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment Options Domenic A. Sica

Chapter 11 Ultrafiltration and Heart Failure

Paul Chacko, Donald Kikta Jr., William T. Abraham

Part Four Advances in Nephropathy Management: Influences on CVD RiskChapter 12 Combination Therapy in Hypertension Treatment

Raymond V. Oliva and George L. Bakris

Chapter 13 Medication Adherence in Heart Failure

Daniel E. Hilleman and Jennifer A. Campbell

Chapter 14 New Markers of Vascular Risk

David Davidson and Michael H. Davidson

Chapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD

Raghu V. Durvasula and Katherine R. Tuttle

Mohammed Shakaib and George L. Bakris

Chapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient

Biff F. Palmer

Chapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications

Ivan D. Hanson and Peter A. McCullough

Part Three Management of Kidney Associated Clinical ProblemsChapter 7 Hyperkalemia Risk and Treatment of Heart Failure

Julian Segura and Luis M. Ruilope

Chapter 8 Management of Heart Failure with Renal Artery Ischaemia

Andrew K. Roy and Patrick Murray

Chapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure

Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir

Chapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment Options Domenic A. Sica

Chapter 11 Ultrafiltration and Heart Failure

Paul Chacko, Donald Kikta Jr., William T. Abraham

Part Four Advances in Nephropathy Management: Influences on CVD RiskChapter 12 Combination Therapy in Hypertension Treatment

Raymond V. Oliva and George L. Bakris

Chapter 13 Medication Adherence in Heart Failure

Daniel E. Hilleman and Jennifer A. Campbell

Chapter 14 New Markers of Vascular Risk

David Davidson and Michael H. Davidson

Chapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD

Raghu V. Durvasula and Katherine R. Tuttle